Extract
Over the past few years, early career members of the European Respiratory Society (ERS) have expressed an interest in gaining exposure to industry, to complement their experience in the academic sector as well as to widen their career perspectives.
Abstract
Recipients of the ERS Fellowship in Industry discuss their experiences http://ow.ly/1gcE30hMe89
Acknowledgements
We are indebted in appreciation to Pascal Pfister, the senior coordinator of this fellowship, for making this project become a reality; to Robert Fogel, Michael Larbig and Xavier Jaumont (our supervisors) for their kind and competent mentorship; to Caroline Schumacher, our administrative expert, for her precious help in all the administrative matters; to Kostas Kostikas for giving us the impulse to write this paper and for his kind support throughout the fellowship; and to all our colleagues from the Medical Affairs, Development and Commercial departments for providing a very friendly environment, allowing for a quick integration and making us feel a part of the whole Novartis Respiratory team.
Footnotes
Conflict of interest P. Katsaounou has received honoraria, and advisory and travel expenses from Pfizer, Chiesi, Boehringer Ingelheim, GlaxoSmithKline and Novartis.
Conflict of interest S. Frent reports personal fees (speaker fees) from Astra Zeneca and Boehringer Ingelheim, and accommodation and travel expenses for the ERS Congresses in 2016 and 2017 from Novartis, all outside the submitted work; he is a Former European Respiratory Society Fellow at Novartis.
- Copyright ©ERS 2018
Breathe articles are open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.